Cardiac Stents May Have Tingling Effect on Some Patients

	Tweet

Coronary stents are commonly used to open blocked arteries of patients with coronary artery disease. Increasingly, stents that release a drug that prevents recurrent narrowing of the coronary stents are used, and may cause numbness and tingling in some patients.

Paclitaxel-eluting stents (PESs) are commonly used to delivery the drug directly to the wall of the coronary artery and limit the growth of scar within the stents. Paclitaxel is a microtubule-stabilizing agent also used in the treatment of ovarian and breast cancer and its principal adverse effect is a sensory neuropathy. 

A 65-year old man presented with symmetric numbness in all his extremities. In 2003 he had Angioplasty and two PESs were deployed for angina. Three days later he noticed paresthesiae in his hands and feet. He had further angina and had four more PESs inserted in 2005 and 2006. His tingling worsened a few days subsequent to each stent placement. Neurological examination demonstrated normal muscle strength, mild vibration loss distally in his feet, and moderate, symmetric temperature and pinprick loss in his legs below his groin and in his hands below the elbows. Muscle stretch reflexes were symmetric and his gait was normal. Nerve conduction studies revealed findings suggestive of a generalized sensory ganglionopathy.

Neuropathy is seen in about 10% of patients receiving paclitaxel for cancer. It is postulated that in this patient, who had multiple PES over a 3-year period there may have been sufficient systemic release of paclitaxel resulting in sensory neuropathy. “Patients and physicians should be aware of this rare complication of a paclitaxel-eluting stent,” said lead author, Dr. Jayashri Srinivasan of Lahey Clinic in Burlington, Massachusetts.

The complete findings and results of this study are being presented at the American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) 54th Annual Meeting in Phoenix, AZ, at the JW Marriott Desert Ridge, October 14-17, 2007. The AANEM is the largest organization worldwide, with over 5000 members dedicated to advancing neuromuscular, musculoskeletal, and electrodiagnostic medicine.

Source: American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM)

RELATED STORIES:
Scientists turn skin cells into beating heart muscle   Too many people get angioplasties, study suggests   New Blood Thinner May Lower Chances of Clots in High-Risk Heart Patients: FDA   Heart Damage After Chemo Linked to Stress in Cardiac Cells   What’s good or bad for the heart, may be the same for the brain   Warfarin in Heart Failure   Increased Sudden Cardiac Death Rate Among HIV Patients   Air pollution level changes in Beijing linked with biomarkers of cardiovascular disease   Lack of basic evidence hampering prevention of sudden heart attacks in sport   Blacks Less Likely to Get Help on Scene After Cardiac Arrest: Study   Heart attack patients taken to PCI hospitals first treated faster   Cameron Health’s under-skin ICD safe, effective

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]